Global Direct To Consumer Pharmaceutical Advertising Market
Global Direct To Consumer Pharmaceutical Advertising Market

Direct To Consumer Pharmaceutical Advertising Comprehensive Study by Medium (Television, Magazines, Online platforms) Players and Region - Global Market Outlook to 2026

Direct To Consumer Pharmaceutical Advertising Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Oct 2021 Edition 246 Pages 218 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Direct To Consumer Pharmaceutical Advertising Market Overview:
Direct-to-consumer advertising of prescription drugs is a powerful force in the health care market. Proponents claim that good direct-to-consumer advertising educates and empowers patients in their relationship with their health care providers. Furthermore, they assert that direct-to-consumer advertising provides an opportunity for patients to talk with providers about under-diagnosed and under-treated medical conditions and may lead to improved health outcomes. In order to be successful at this task, physicians need to be optimally informed about direct-to-consumer advertising and its effects on health care practice.

Growth Drivers
  • Increasing their expenditure on advertising of drug

Roadblocks
  • Limited Expertise and higher cost of professional services

Opportunities
  • Rise in campaigns activities of marketing for new drug

Challenges
  • Rise in case of false advertisements or misleading


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Johnson & Johnson (united States), Pfizer (United States), Merck & Co (United States) and GlaxoSmithKline and Roche (United Kingdom). Considering Market by Medium, the sub-segment i.e. Television will boost the Direct To Consumer Pharmaceutical Advertising market.

What Can be Explored with the Direct To Consumer Pharmaceutical Advertising Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Direct To Consumer Pharmaceutical Advertising Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Direct To Consumer Pharmaceutical Advertising
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Direct To Consumer Pharmaceutical Advertising market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Direct To Consumer Pharmaceutical Advertising market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Direct To Consumer Pharmaceutical Advertising Providers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global Direct To Consumer Pharmaceutical Advertising Market?
The Direct To Consumer Pharmaceutical Advertising market is expected to see a CAGR of % during projected year 2020 to 2026.

2. Who are the top performing companies in Direct To Consumer Pharmaceutical Advertising Market?
Top performing companies in the Global Direct To Consumer Pharmaceutical Advertising market are Johnson & Johnson (united States), Pfizer (United States), Merck & Co (United States) and GlaxoSmithKline and Roche (United Kingdom), to name a few.

3. What trending factors would impact Direct To Consumer Pharmaceutical Advertising Market growth most?
"Digital transformation in media and the publishing business" is seen as one of major influencing trends for Direct To Consumer Pharmaceutical Advertising Market during projected period 2020-2026.

Report Objectives / Segmentation Covered
By Medium
  • Television
  • Magazines
  • Online platforms

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing their expenditure on advertising of drug
    • 3.3. Market Challenges
      • 3.3.1. Rise in case of false advertisements or misleading
    • 3.4. Market Trends
      • 3.4.1. Digital transformation in media and the publishing business
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Direct To Consumer Pharmaceutical Advertising, by Medium and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Direct To Consumer Pharmaceutical Advertising (Value)
      • 5.2.1. Global Direct To Consumer Pharmaceutical Advertising by: Medium (Value)
        • 5.2.1.1. Television
        • 5.2.1.2. Magazines
        • 5.2.1.3. Online platforms
      • 5.2.2. Global Direct To Consumer Pharmaceutical Advertising Region
        • 5.2.2.1. South America
          • 5.2.2.1.1. Brazil
          • 5.2.2.1.2. Argentina
          • 5.2.2.1.3. Rest of South America
        • 5.2.2.2. Asia Pacific
          • 5.2.2.2.1. China
          • 5.2.2.2.2. Japan
          • 5.2.2.2.3. India
          • 5.2.2.2.4. South Korea
          • 5.2.2.2.5. Taiwan
          • 5.2.2.2.6. Australia
          • 5.2.2.2.7. Rest of Asia-Pacific
        • 5.2.2.3. Europe
          • 5.2.2.3.1. Germany
          • 5.2.2.3.2. France
          • 5.2.2.3.3. Italy
          • 5.2.2.3.4. United Kingdom
          • 5.2.2.3.5. Netherlands
          • 5.2.2.3.6. Rest of Europe
        • 5.2.2.4. MEA
          • 5.2.2.4.1. Middle East
          • 5.2.2.4.2. Africa
        • 5.2.2.5. North America
          • 5.2.2.5.1. United States
          • 5.2.2.5.2. Canada
          • 5.2.2.5.3. Mexico
  • 6. Direct To Consumer Pharmaceutical Advertising: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (united States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck & Co (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GlaxoSmithKline and Roche (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
  • 7. Global Direct To Consumer Pharmaceutical Advertising Sale, by Medium and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Direct To Consumer Pharmaceutical Advertising (Value)
      • 7.2.1. Global Direct To Consumer Pharmaceutical Advertising by: Medium (Value)
        • 7.2.1.1. Television
        • 7.2.1.2. Magazines
        • 7.2.1.3. Online platforms
      • 7.2.2. Global Direct To Consumer Pharmaceutical Advertising Region
        • 7.2.2.1. South America
          • 7.2.2.1.1. Brazil
          • 7.2.2.1.2. Argentina
          • 7.2.2.1.3. Rest of South America
        • 7.2.2.2. Asia Pacific
          • 7.2.2.2.1. China
          • 7.2.2.2.2. Japan
          • 7.2.2.2.3. India
          • 7.2.2.2.4. South Korea
          • 7.2.2.2.5. Taiwan
          • 7.2.2.2.6. Australia
          • 7.2.2.2.7. Rest of Asia-Pacific
        • 7.2.2.3. Europe
          • 7.2.2.3.1. Germany
          • 7.2.2.3.2. France
          • 7.2.2.3.3. Italy
          • 7.2.2.3.4. United Kingdom
          • 7.2.2.3.5. Netherlands
          • 7.2.2.3.6. Rest of Europe
        • 7.2.2.4. MEA
          • 7.2.2.4.1. Middle East
          • 7.2.2.4.2. Africa
        • 7.2.2.5. North America
          • 7.2.2.5.1. United States
          • 7.2.2.5.2. Canada
          • 7.2.2.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Direct To Consumer Pharmaceutical Advertising: by Medium(USD Million)
  • Table 2. Direct To Consumer Pharmaceutical Advertising Television , by Region USD Million (2015-2020)
  • Table 3. Direct To Consumer Pharmaceutical Advertising Magazines , by Region USD Million (2015-2020)
  • Table 4. Direct To Consumer Pharmaceutical Advertising Online platforms , by Region USD Million (2015-2020)
  • Table 5. South America Direct To Consumer Pharmaceutical Advertising, by Country USD Million (2015-2020)
  • Table 6. South America Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 7. Brazil Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 8. Argentina Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 9. Rest of South America Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 10. Asia Pacific Direct To Consumer Pharmaceutical Advertising, by Country USD Million (2015-2020)
  • Table 11. Asia Pacific Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 12. China Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 13. Japan Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 14. India Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 15. South Korea Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 16. Taiwan Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 17. Australia Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 18. Rest of Asia-Pacific Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 19. Europe Direct To Consumer Pharmaceutical Advertising, by Country USD Million (2015-2020)
  • Table 20. Europe Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 21. Germany Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 22. France Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 23. Italy Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 24. United Kingdom Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 25. Netherlands Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 26. Rest of Europe Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 27. MEA Direct To Consumer Pharmaceutical Advertising, by Country USD Million (2015-2020)
  • Table 28. MEA Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 29. Middle East Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 30. Africa Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 31. North America Direct To Consumer Pharmaceutical Advertising, by Country USD Million (2015-2020)
  • Table 32. North America Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 33. United States Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 34. Canada Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 35. Mexico Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2015-2020)
  • Table 36. Company Basic Information, Sales Area and Its Competitors
  • Table 37. Company Basic Information, Sales Area and Its Competitors
  • Table 38. Company Basic Information, Sales Area and Its Competitors
  • Table 39. Company Basic Information, Sales Area and Its Competitors
  • Table 40. Direct To Consumer Pharmaceutical Advertising: by Medium(USD Million)
  • Table 41. Direct To Consumer Pharmaceutical Advertising Television , by Region USD Million (2021-2026)
  • Table 42. Direct To Consumer Pharmaceutical Advertising Magazines , by Region USD Million (2021-2026)
  • Table 43. Direct To Consumer Pharmaceutical Advertising Online platforms , by Region USD Million (2021-2026)
  • Table 44. South America Direct To Consumer Pharmaceutical Advertising, by Country USD Million (2021-2026)
  • Table 45. South America Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 46. Brazil Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 47. Argentina Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 48. Rest of South America Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 49. Asia Pacific Direct To Consumer Pharmaceutical Advertising, by Country USD Million (2021-2026)
  • Table 50. Asia Pacific Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 51. China Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 52. Japan Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 53. India Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 54. South Korea Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 55. Taiwan Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 56. Australia Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 57. Rest of Asia-Pacific Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 58. Europe Direct To Consumer Pharmaceutical Advertising, by Country USD Million (2021-2026)
  • Table 59. Europe Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 60. Germany Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 61. France Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 62. Italy Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 63. United Kingdom Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 64. Netherlands Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 65. Rest of Europe Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 66. MEA Direct To Consumer Pharmaceutical Advertising, by Country USD Million (2021-2026)
  • Table 67. MEA Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 68. Middle East Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 69. Africa Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 70. North America Direct To Consumer Pharmaceutical Advertising, by Country USD Million (2021-2026)
  • Table 71. North America Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 72. United States Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 73. Canada Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 74. Mexico Direct To Consumer Pharmaceutical Advertising, by Medium USD Million (2021-2026)
  • Table 75. Research Programs/Design for This Report
  • Table 76. Key Data Information from Secondary Sources
  • Table 77. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Direct To Consumer Pharmaceutical Advertising: by Medium USD Million (2015-2020)
  • Figure 5. South America Direct To Consumer Pharmaceutical Advertising Share (%), by Country
  • Figure 6. Asia Pacific Direct To Consumer Pharmaceutical Advertising Share (%), by Country
  • Figure 7. Europe Direct To Consumer Pharmaceutical Advertising Share (%), by Country
  • Figure 8. MEA Direct To Consumer Pharmaceutical Advertising Share (%), by Country
  • Figure 9. North America Direct To Consumer Pharmaceutical Advertising Share (%), by Country
  • Figure 10. Global Direct To Consumer Pharmaceutical Advertising share by Players 2020 (%)
  • Figure 11. BCG Matrix for key Companies
  • Figure 12. Johnson & Johnson (united States) Revenue, Net Income and Gross profit
  • Figure 13. Johnson & Johnson (united States) Revenue: by Geography 2020
  • Figure 14. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 15. Pfizer (United States) Revenue: by Geography 2020
  • Figure 16. Merck & Co (United States) Revenue, Net Income and Gross profit
  • Figure 17. Merck & Co (United States) Revenue: by Geography 2020
  • Figure 18. GlaxoSmithKline and Roche (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 19. GlaxoSmithKline and Roche (United Kingdom) Revenue: by Geography 2020
  • Figure 20. Global Direct To Consumer Pharmaceutical Advertising: by Medium USD Million (2021-2026)
  • Figure 21. South America Direct To Consumer Pharmaceutical Advertising Share (%), by Country
  • Figure 22. Asia Pacific Direct To Consumer Pharmaceutical Advertising Share (%), by Country
  • Figure 23. Europe Direct To Consumer Pharmaceutical Advertising Share (%), by Country
  • Figure 24. MEA Direct To Consumer Pharmaceutical Advertising Share (%), by Country
  • Figure 25. North America Direct To Consumer Pharmaceutical Advertising Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Johnson & Johnson (united States)
  • Pfizer (United States)
  • Merck & Co (United States)
  • GlaxoSmithKline and Roche (United Kingdom)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation